According to Cancer Research UK, there are around 6,600 new liver cancer cases in the UK every year, and around 5,830 people ...

For unresectable or metastatic liver cancer, the TPST-1120-301 trial of amezalpat combination therapy has received a “Study ...

Learn how personalised treatments are providing new hope with tailored therapies offering better outcomes for patients ...

The agency has approved Ziihera for adults with previously treated, unresectable or metastatic HER2-positive biliary tract ...

Among the 62 patients with unresectable or metastatic HER2-positive (IHC 3+) disease, zanidatamab monotherapy induced ...

Learn about HMGB1's crucial role in liver diseases, its pathways and therapeutic potential that can treat liver diseases.

The FDA approved a phase 3 trial to assess amezalpat with the current standard of care in unresectable or metastatic ...